Suppr超能文献

妊娠合并重度子痫前期时铜蓝蛋白的胎盘表达

Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia.

作者信息

Guller Seth, Buhimschi Catalin S, Ma Yula Y, Huang Se Te J, Yang Liubin, Kuczynski Edward, Zambrano Eduardo, Lockwood Charles J, Buhimschi Irina A

机构信息

Department of Obstetrics/Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520-8063, USA.

出版信息

Lab Invest. 2008 Oct;88(10):1057-67. doi: 10.1038/labinvest.2008.74. Epub 2008 Aug 4.

Abstract

There is consensus that ischemia/reperfusion injury associated with preeclampsia (PE) promotes both placental damage and the release of factors leading to maternal endothelium dysfunction, a hallmark of this potentially life-threatening syndrome. These factors include plasminogen activator inhibitor-1 (PAI-1) and soluble fms-like tyrosine kinase-1 (sFlt-1). The goal of this study was to further characterize placental factors involved in the pathophysiology of PE. Thus, DNA microarray gene profiling was utilized to identify mRNA differentially regulated in placentas from women with severe PE compared to both preterm (PC) and term control (TC) groups. Microarray studies detected an upregulation of mRNA for ceruloplasmin, a copper-containing iron transport protein with antioxidant ferroxidase properties, in PE compared to PC and TC placentas, respectively. Quantitative real-time PCR confirmed these results by demonstrating significant increases in ceruloplasmin mRNA in PE vs PC and TC placentas. Supporting previous reports, the expression of sFlt-1 and PAI-1 were also upregulated in PE placentas. Immunohistochemistry localized ceruloplasmin to the intervillous space in PE and PC placentas, whereas stronger syncytial staining was noted in PE. Western blotting confirmed a significant increase in ceruloplasmin levels in placental tissue in PE compared to PC groups. PCR identified the presence of mRNA for ceruloplasmin in primary cultures of syncytiotrophoblasts, but not villous-derived fibroblasts, suggesting that syncytium is the site of ceruloplasmin synthesis in placenta. Hypoxic treatment (1% O(2)) of syncytiotrophoblasts enhanced levels of ceruloplasmin mRNA approximately 25-fold, a significantly greater upregulation than that noted for PAI-1 and sFlt-1, suggesting that enhanced ceruloplasmin expression is a sensitive marker of syncytial hypoxia. We suggest that syncytial ceruloplasmin and its associated ferroxidase activity, induced by the hypoxia accompanying severe PE, is important in an endogenous cellular program to mitigate the damaging effects of subsequent reperfusion injury at this site.

摘要

人们普遍认为,与子痫前期(PE)相关的缺血/再灌注损伤会促进胎盘损伤以及导致母体血管内皮功能障碍的因子释放,而血管内皮功能障碍是这种潜在威胁生命综合征的一个标志。这些因子包括纤溶酶原激活物抑制剂-1(PAI-1)和可溶性fms样酪氨酸激酶-1(sFlt-1)。本研究的目的是进一步表征参与PE病理生理学的胎盘因子。因此,利用DNA微阵列基因谱分析来鉴定与早产(PC)组和足月对照组(TC)相比,重度PE女性胎盘组织中差异表达的mRNA。微阵列研究检测到,与PC组和TC组胎盘相比,铜蓝蛋白(一种具有抗氧化铁氧化酶特性的含铜铁转运蛋白)的mRNA在PE组胎盘中上调。定量实时PCR通过证明PE组胎盘与PC组和TC组胎盘相比铜蓝蛋白mRNA显著增加,证实了这些结果。与先前的报道一致,sFlt-1和PAI-1的表达在PE组胎盘中也上调。免疫组织化学将铜蓝蛋白定位在PE组和PC组胎盘的绒毛间隙中,而在PE组中观察到更强的合体滋养层染色。蛋白质免疫印迹法证实,与PC组相比,PE组胎盘组织中铜蓝蛋白水平显著增加。PCR鉴定出在合体滋养层细胞原代培养物中存在铜蓝蛋白的mRNA,但在绒毛来源的成纤维细胞中不存在,这表明合体滋养层是胎盘中铜蓝蛋白合成的部位。对合体滋养层细胞进行低氧处理(1% O₂)可使铜蓝蛋白mRNA水平提高约25倍,上调幅度明显大于PAI-1和sFlt-1,这表明铜蓝蛋白表达增强是合体滋养层低氧的一个敏感标志物。我们认为,重度PE伴随的低氧诱导的合体滋养层铜蓝蛋白及其相关的铁氧化酶活性,在减轻该部位随后再灌注损伤的内源性细胞程序中很重要。

相似文献

引用本文的文献

2
Iron and Pregnancy.铁与妊娠
Adv Exp Med Biol. 2025;1480:327-343. doi: 10.1007/978-3-031-92033-2_21.
5
7
Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.铜蓝蛋白在代谢性疾病病理学中的分子功能
Diabetes Metab Syndr Obes. 2022 Mar 3;15:695-711. doi: 10.2147/DMSO.S346648. eCollection 2022.

本文引用的文献

9
New insights into the biology of preeclampsia.子痫前期生物学的新见解。
Biol Reprod. 2006 May;74(5):772-6. doi: 10.1095/biolreprod.105.045997. Epub 2006 Jan 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验